NASDAQ: SBFMSunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?
Insider buying vs selling
Have Sunshine Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Camille Sebaaly | CFOSecretary | 2022-06-03 | 25,000 | $1.22 | $30.50kBuy |
| Steve N. Slilaty | Chief Executive Officer | 2022-02-18 | 990,000 | $0.10 | $99.00kSell |
SBFM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SBFM insiders and whales buy or sell their stock.
SBFM Shareholders
What type of owners hold Sunshine Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bridgeway Capital Management LLC | 3.01% | 568,400 | $457.56k | Institution |
| Camille Sebaaly | 0.76% | 144,465 | $116.29k | Insider |
| Virtu Financial LLC | 0.25% | 47,861 | $38.53k | Institution |
| Bank Of Montreal | 0.16% | 31,000 | $24.96k | Institution |
| Two Sigma Securities LLC | 0.11% | 20,722 | $16.68k | Institution |
| Geode Capital Management LLC | 0.11% | 20,179 | $16.24k | Institution |
| Dakota Wealth Management | 0.11% | 20,000 | $16.10k | Institution |
| Steve N. Slilaty | 0.05% | 10,000 | $8.05k | Insider |
| Tower Research Capital LLC Trc | 0.04% | 8,128 | $6.54k | Institution |
| Advisor Group Holdings Inc | 0.04% | 7,528 | $6.06k | Institution |
SBFM vs Pharmaceutical Stocks
Sunshine Biopharma Stock Ownership FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.